Title:
ヒトインターロイキン4およびヒトインターロイキン13のアンタゴニストであるペプチド
Document Type and Number:
Japanese Patent JP4394931
Kind Code:
B2
Abstract:
To provide a method for producing a synthetic peptide having a new amino acid sequence having antagonistic action on hIL-4 as well as hIL-13 and provide a pharmaceutical composition containing the synthetic peptide and useful for the treatment of allergic diseases.
The invention relates to a peptide having a new amino acid sequence, an antagonist of human interleukin-4 and human interleukin-13 containing the peptide, and a pharmaceutical composition containing the peptide and useful for the treatment of allergic diseases.
COPYRIGHT: (C)2005,JPO&NCIPI
Inventors:
Fukumi Ito
Ikuo Fujii
Ikuo Fujii
Application Number:
JP2003398464A
Publication Date:
January 06, 2010
Filing Date:
November 28, 2003
Export Citation:
Assignee:
Daiichi Sankyo Co., Ltd.
International Classes:
A61K38/00; C07K14/00; A61P37/08
Domestic Patent References:
| JP10245397A | ||||
| JP10503371A |
Other References:
BARNES, P.J.,"Cytokine-directed therapies for asthma.",J. ALLERGY CLIN. IMMUNOL.,2001年 8月,Vol.108, No.2 Suppl.,S72-S76
Attorney, Agent or Firm:
Kyousei Tamura
Samejima Mutsumi
Nagatoshi Shinagawa
Yasushi Morimoto
Shinichiro Yamanaka
Samejima Mutsumi
Nagatoshi Shinagawa
Yasushi Morimoto
Shinichiro Yamanaka